期刊文献+

核周型抗中性粒细胞胞质抗体和抗酿酒酵母抗体在炎症性肠病中的临床意义 被引量:6

Clinical Significance of Perinuclear Antineutrophil Cytoplasmic Antibodies and Anti-Saccharomyces cerevisiae Antibodies in Inflammatory Bowel Disease
下载PDF
导出
摘要 背景:核周型抗中性粒细胞胞质抗体(pANCA)和抗酿酒酵母抗体(ASCA)是一组与炎症性肠病(IBD)密切相关的免疫球蛋白,但对溃疡性结肠炎(UC)、克罗恩病(CD)的诊断和鉴别诊断的价值仍有待进一步验证。目的:探讨pANCA和ASCA在UC与CD诊断和鉴别诊断中的意义。方法:以酶联免疫吸附测定(ELISA)检测64例UC、62例CD和56例健康对照者的血清pANCA、ASCA水平和阳性率,分析pANCA、ASCA及其组合的诊断敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。结果:UC组血清pANCA水平[(584.22±347.70)pg/ml对(304.99±211.10)pg/ml和(390.92±82.82)pg/ml,P<0.01]和阳性率(50.0%对14.5%和14.3%,P<0.01)显著高于CD组和健康对照组,三组间血清ASCA水平和阳性率无明显差异。pANCA^+和pANCA^+/ASCA-诊断UC的敏感性、特异性、PPV和NPV分别为50.0%、85.7%、80.0%、60.0%和42.2%、89.3%、81.8%、57.5%,ASCA^+和ASCA^+/pANCA^-诊断CD的敏感性、特异性、PPV和NPV分别为8.1%、87.5%、41.7%、46.2%和3.2%、91.1%、28.6%、45.9%。结论:pANCA阳性有利于UC的诊断。pANCA/ASCA联合检测有助于鉴别UC,但对CD诊断价值不高。 Background: Perinuclear antineutrophil cytoplasmic antibodies (pANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) are immunoglobulins closely related with inflammatory bowel disease (IBD). The role of pANCA and ASCA in the diagnosis of ulcerative colitis (UC) and Crohn's disease (CD) remains further verification. Aims: To investigate the significance of pANCA and ASCA in the diagnosis and differential diagnosis of UC and CD. Methods: Serum samples were obtained from 64 patients with UC, 62 patients with CD and 56 healthy controls. Levels and positivity rates of pANCA and ASCA were determined by enzyme-linked immunosorbent assay (ELISA). The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of pANCA, ASCA and their combination were analyzed. Results: Serum pANCA level was significantly higher in UC group than that in CD group and healthy controls [(584.22±347.70) pg/ml vs. (304.99±211.10) pg/ml and (390.92±82.82) pg/ml, P〈0.01], so was the positivity rate of pANCA (50.0% vs. 14.5% and 14.3%, P〈0.01). The level and positivity rate of serum ASCA among these three groups had no significant difference. The sensitivity, specificity, PPV and NPV of pANCA^+ and pANCA^+/ASCA^- in diagnosis of UC were 50.0%, 85.7%, 80.0%, 60.0% and 42.2%, 89.3%, 81.8%, 57.5%, respectively, and those of ASCA^+ and ASCA^+/ pANCA^-in diagnosis ofCD were 8.1%, 87.5%, 41.7%, 46.2% and 3.2%, 91.1%, 28.6%, 45.9%, respectively. Conclusions: Positive pANCA favors the diagnosis of UC. Detection of pANCA together with ASCA is helpful for the differential diagnosis of UC, but is not of high value for the diagnosis of CD.
出处 《胃肠病学》 2009年第11期674-677,共4页 Chinese Journal of Gastroenterology
基金 上海市重点学科建设项目资助(项目编号:Y0205)
关键词 结肠炎 溃疡性 CROHN病 抗体 抗中性白细胞胞质 抗体 抗酿酒酵母 敏感性与特异性 Colitis, Ulcerative Crohn Disease Antibodies, Antineutrophil Cytoplasmic Antibodies, Anti-Saccharomyces cerevisiae Sensitivity and Specificity
  • 相关文献

参考文献12

  • 1Bansi DS, Chapman RW, Fleming KA. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol, 1996, 8 (9): 881-885.
  • 2Frenzer A, Fierz W, Rundler E, et al. Atypical, cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. J Gastroenterol Hepatol, 1998, 13 (9): 950-954.
  • 3张静,韩英.ANCA、ASCA血清学检测与炎症性肠病[J].现代消化及介入诊疗,2006,11(3):180-182. 被引量:1
  • 4Solberg IC, Lygren I, Cvancarova M, et al; IBSEN Study Group. Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease. Inflamm Bowel Dis, 2009, 15 (3):406- 414.
  • 5Zholudev A, Zurakowski D, Young W, et al. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol, 2004, 99 (11): 2235- 2241.
  • 6高翔,胡品津,何瑶,廖山婴,彭穗,陈旻湖.炎症性肠病患者血清中自身抗体检测的临床意义[J].中华内科杂志,2005,44(6):428-430. 被引量:39
  • 7何淳,张蜀澜,李永哲,张海莹,佟大伟,胡朝军.炎症性肠病患者中四种自身抗体联合检测的临床意义[J].标记免疫分析与临床,2008,15(5):268-271. 被引量:21
  • 8Walker LJ, Aldhous MC, Drummond HE, et al. Anti- Saceharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol, 2004, 135 (3): 490-496.
  • 9Hisabe T, Matsui T, Sakurai T, et al. Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value. J Gastroenterol, 2003, 38 (2): 121-126.
  • 10Lawrance IC, Murray K, Hall A, et al. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am J Gastroenterol, 2004, 99 (11): 2186-2194.

二级参考文献30

  • 1S Desplat-Jégo,C Johanet,A Escande,J Goetz,N Fabien,N Olsson,E Ballot,J Sarles,JJ Baudon,JC Grimaud,M Veyrac,P Chamouard,RL Humbel.Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: Results of a multicent[J].World Journal of Gastroenterology,2007,13(16):2312-2318. 被引量:24
  • 2[1]Bansi DS,Chapman RW,Fleming KA.Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.Eur J Gastroenterol Hepatol 1996;8:881-885.
  • 3[2]Frenzer A,Fierz W,Rundler E,et al.Atypical,cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.J Gastroenterol Hepatol 1998 ;13:950-954.
  • 4[3]Lawrance IC,Murray K,Hall A,et al.A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients.Am J Gastroenterol 2004;99:2186-2194.
  • 5[4]Basu D,Lopez I,Kulkarni A,et al.Impact of race and ethnicity on inflammatory bowel disease.Am J Gastroenterol 2005;100:2254-2261.
  • 6[6]Reumaux D,Delecourt L,Colombel JF,et al.Anti-neutrophil cytoplasmic autoantibodies in relatives of patients with ulcerative colitis.Gastroenterology 1992;103:1706.
  • 7[7]Sutton CL,Yang H,Li Z,et al.Familial expression of anti-saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.Gut 2000;46:58-63.
  • 8[8]Hugot JP,Chamaillard M,Zouali H,et al.Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.Nature 2001;411:599-603.
  • 9[9]Annese V,Andreoli A,Andriulli A,et al.Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis:a GISC study.Am J Gastroenterol 2001;96:2407-2412.
  • 10[10]Freeman HJ.Inflammatory bowel disease with cytoplasmic-staining antineutrophil cytoplasmic antibody and extensive colitis.Can J Gastroenterol 1998;12:279-282.

共引文献54

同被引文献48

  • 1高翔,胡品津,何瑶,廖山婴,彭穗,陈旻湖.炎症性肠病患者血清中自身抗体检测的临床意义[J].中华内科杂志,2005,44(6):428-430. 被引量:39
  • 2欧阳钦,Rakesh Tandon,KL Goh,潘国宗,KM Fock,Claudio Fiocchi,SK Lam,萧树东,张虎,梁红亮,王玉芳.亚太地区炎症性肠病处理共识意见(一)[J].胃肠病学,2006,11(4):233-238. 被引量:123
  • 3Seksik P,Vasquez N,Lepage P,et al.A low proportion of f.firmicutes on resected ileal Crohn's disease mucosa is associatedwith endoscopic recurrence at three months[J].Gut,2007,56(Suppl 3):A122.
  • 4Lawrance IC,Murray K,Hall A,et al.A prospectivecomparative study of ASCA and pANCA in Chinese andCaucasian IBD patients[J].Am J Gastroenterol,2004,99(11):2186.
  • 5Sartor RB.Therapeutic manipulation of the enteric microflorain inflammatory boweldiseases:antibiotics,probiotics andprebiotics[J].Gastroenterology,2004,126(6):1620-1633.
  • 6Solem CA,Loftus EV,Tremaine WJ,et al.Correlation of C-reactive protein with clinical endoscopic histologic andradiographic activity in inflammatory bowel diseases[J].Inflamm Bowel Dis,2005,11(8):707.
  • 7Sugi K,Saitoh O,Hirata I,et al.Fecal lactoferrin as a markerfor disease activity in inflammatory bowel disease:comparisonwith other neutrophil derived proteins[J].Am JGastroenterol,1996,91(5):927-934.
  • 8Costa F,Mumolo MG,Bellini M,et al.Role of faecalcalprotectin as non invasive marker of intestinal inflammation[J].Dig Liver Dis,2003,35(3):642-647.
  • 9Von Roon AC,Karamountzos L,Purkayastha S.Diagnosticprecision of fecal calprotectin for inflammatory bowel diseaseand colorectal malignancy[J].Am J Gastroenterol,2007,102(4):803-813.
  • 10Quinton JF,Sendid B,Reumaux D,et al.Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease:prevalence and diagnostic role[J].Gut,1998,42 (6):788-791.

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部